John was Senior Clinical Development Leader at 23andMe, and Vice President, Clinical Development at Aimmune Therapeutics. John Matthews joined ReCode Therapeutics in 2023.
John Matthews is currently
Create your alert
to follow the career of John Matthews.
John Matthews has a Bachelor of Science in Medicine from UMDS St Thomas Hospital and a PhD in Respiratory Pharmacology from Imperial College London.
They have also studied at Imperial College London :
Find more alumni from Imperial College London
Do you need to know more about John Matthews? More results.
Report an error
Update the org chart details of John Matthews.
Here are a few tips for establishing great contacts.
Discover the organization charts of your favorite companies.
Spot the influential executives using our search tools.
Receive notifications when executive positions change.